Sort by
Keyphrases
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
68%
Chimeric Antigen Receptor T Cells (CAR-T)
67%
Viral Infection
66%
Adoptive Cell Therapy
55%
Virus-specific T Cells
51%
Pediatric Hematology
44%
Solid Tumors
44%
Sulfhemoglobinemia
33%
Houston
33%
Oncology Center
33%
Allogeneic Hematopoietic Cell
33%
Oncology Patients
33%
Cell Therapy
33%
COVID-19 Outcomes
33%
Nutritional Iron Deficiency Anemia
33%
Texas
33%
Uveal Melanoma
33%
Costimulatory Molecules
33%
Leukemia-lymphoma
33%
Cardiac Toxicity
33%
Allogeneic
33%
Lymphodepletion
33%
Plan-Do-Study-Act Cycle
33%
Systemic Infection
33%
Immune Therapy
33%
Haematopoietic Stem Cell Transplant Recipients
33%
Prolonged Cytopenia
33%
Specific T Cells
33%
Cancer Immunotherapy
33%
Solid Organ Transplantation
33%
Young children
33%
Receptor-based
33%
Critically Ill
33%
Urinary Tract Infection
33%
T Cell Receptor
33%
Emergency Department
33%
Team-based Approach
33%
Mediport
33%
Cell Infusion
33%
Thiotepa
33%
Transplantation
33%
Alemtuzumab
33%
Melphalan
33%
Fludarabine
33%
Inborn Errors of Immunity
33%
Hematology
25%
COVID-19
25%
Cytopenia
25%
Metastatic Uveal Melanoma
22%
Pulmonary Hypertension
22%
Medicine and Dentistry
Cell Therapy
100%
T Cell
92%
Infusion
53%
Cell Transplantation
47%
Hematopoietic Cell
47%
Chimeric Antigen Receptor T-Cell
47%
Hematopoietic Stem Cell Transplantation
42%
Pediatric Hematology
41%
Effector Cell
41%
Solid Malignant Neoplasm
41%
Patient with Leukemia
33%
Sulfhemoglobinemia
33%
Cardiotoxicity
33%
COVID-19
33%
Echocardiography
33%
Cytopenia
33%
Urinary Tract Infection
33%
Hypochromic Anemia
33%
Emergency Department
33%
Oncology
33%
T Lymphocyte Receptor
33%
Cancer Immunotherapy
33%
Virus Infection
33%
Uvea Melanoma
33%
Primary Immunodeficiency
33%
Thiotepa
33%
Alemtuzumab
33%
Melphalan
33%
Fludarabine
33%
Transplantation Conditioning
33%
Chimeric Antigen Receptor
28%
Diseases
27%
Virus
26%
Hematology
23%
Cancer
23%
Pulmonary Hypertension
22%
Event Free Survival
20%
T Cell Receptor
19%
Left Ventricular Systolic Dysfunction
16%
Metastatic Uvea Melanoma
16%
Pericardial Fluid
16%
Engraftment
16%
Epstein Barr Virus
16%
Chimeric Antigen Receptor T-Cell Immunotherapy
15%
Pediatrics
14%
Neoplasm
14%
Malignant Neoplasm
14%
Respiratory Distress
13%
Antiviral Therapy
13%
BK Virus
13%
